ISO/TC 212
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 71254 | ISO 22367:2020 | Medical laboratories — Application of risk management to medical laboratories | Standarts spēkā |
| 69802 | ISO 20166-2:2018 | Molecular in vitro diagnostic examinations — Specifications for pre-examinations processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 2: Isolated proteins | Standarts spēkā |
| 72141 | ISO/TS 16782:2016 | Clinical laboratory testing — Criteria for acceptable lots of dehydrated Mueller-Hinton agar and broth for antimicrobial susceptibility testing | Standarts spēkā |
| 69803 | ISO 20166-3:2018 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 3: Isolated DNA | Standarts spēkā |
| 71293 | ISO 35001:2019 | Biorisk management for laboratories and other related organisations | Standarts spēkā |
| 78110 | ISO 20184-3:2021 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 3: Isolated DNA | Standarts spēkā |
| 67217 | ISO 20186-1:2019 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 1: Isolated cellular RNA | Standarts spēkā |
| 54976 | ISO 15197:2013 | In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus | Standarts spēkā |
| 67215 | ISO 20184-1:2018 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 1: Isolated RNA | Standarts spēkā |
| 74605 | ISO 23118:2021 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes in metabolomics in urine, venous blood serum and plasma | Standarts spēkā |
Displaying 11-20 of 143 results.